The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Columvi Roche Products Pty Ltd
Product name
Columvi
Sponsor
Accepted date
Sep-2024
Active ingredients
glofitamab
Proposed indication
For the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
Application type
C (new indication)
Publication date
Sep-2024